Bristol-myers Squibb Drug Patent Portfolio

Bristol-myers Squibb's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol-myers Squibb News

Bristol-Myers Squibb shares rise following broader Opdivo approvals and advancements in AI initiatives.

26 Mar, 2026

US1078421011 Encounters Challenges from Biosimilars Amidst Oncology Patent Expiration - Ad-hoc-news.de

15 Mar, 2026

Delhi High Court greenlights the sale of biosimilar nivolumab for the benefit of the public.

13 Mar, 2026

FACT SHEET: Trump Visits Cincinnati to Discuss Drug Price Reductions Following Support for...

11 Mar, 2026

See More